Active Ingredient(s): Levonorgestrel + Ethinyl Estradiol + Ferrous Bisglycinate
FDA Approved: * January 9, 2018
Category: Birth Control / Contraceptive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Balcoltra Overview

Extended or continuous cycle combined oral contraceptive pills are a packaging of combined oral contraceptive pills (COCPs) that reduce or eliminate the withdrawal bleeding that would occur once every 28 days in traditionally packaged COCPs. It works by reducing the frequency of the pill-free or placebo days. Extended cycle use of COCPs may also be called menstrual suppression,[2] although other hormonal medications or medication delivery systems (hormonal intrauterine devi...

Read more Balcoltra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Balcoltra Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Levonorgestrel + Ethinyl Estradiol + Ferrous Bisglycinate
  • Tablet: 0.02mg + 0.1mg, 0.1mg + 0.02mg + 36.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Balcoltra: (1 result)

Sorted by National Drug Code
  • 75854-602 Balcoltra Kit by Avion Pharmaceuticals

Drugs with one or more similar ingredients: (223 results)